A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer

Clinical trial NCT00632541 · TERMINATED

Trial details

NCT number: NCT00632541
Sponsor: Hoosier Cancer Research Network
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2007-10-01
Primary completion: 2009-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.